-
Loading metrics
Development of an antibody fused with an antimicrobial peptide targeting Pseudomonas aeruginosa: A new approach to prevent and treat bacterial infections
- Kenneth Johnson,
- James C. Delaney,
- Thomas Guillard,
- Fany Reffuveille,
- Jennifer Varin-Simon,
- Kai Li,
- Andrew Wollacott,
- Eric Frapy,
- Surin Mong,
- Hamid Tissire,
- Karthik Viswanathan,
- Faycal Touti,
- Gregory J. Babcock,
- Zachary Shriver ,
- Bradley L. Pentelute,
- Obadiah Plante,
- [ ... ],
-
David Skurnik
Roles Conceptualization, Data curation, Formal analysis, Funding acquisition, Investigation, Methodology, Project administration, Supervision, Validation, Visualization, Writing – original draft, Writing – review & editing
* E-mail: zshriver@visterrainc.com (ZS); david.skurnik@inserm.fr (DS)
Affiliations CNRS, INSERM, Institut Necker Enfants Malades-INEM, F-75015 Paris, France; Faculté de Médecine, University of Paris City, Paris, France, Department of Clinical Microbiology, Fédération Hospitalo-Universitaire Prématurité (FHU PREMA), Necker-Enfants Malades University Hospital, Assistance Publique-Hôpitaux de Paris, University of Paris City, Paris, France, Division of Infectious Diseases, Department of Medicine, Brigham and Women’s Hospital, Harvard Medical School, Boston, Massachusetts, United States of America
⨯ - [ view all ]
- [ view less ]
https://orcid.org/0000-0002-4205-9639
Development of an antibody fused with an antimicrobial peptide targeting Pseudomonas aeruginosa: A new approach to prevent and treat bacterial infections
- Kenneth Johnson,
- James C. Delaney,
- Thomas Guillard,
- Fany Reffuveille,
- Jennifer Varin-Simon,
- Kai Li,
- Andrew Wollacott,
- Eric Frapy,
- Surin Mong,
- Hamid Tissire
-
- Published: September 7, 2023
- https://doi.org/10.1371/journal.ppat.1011612